Status:
UNKNOWN
Effect of Self-acupressure on Middle Ear Barotrauma Associated With Hyperbaric Oxygen Therapy
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Hyperbaric Oxygen Therapy
Middle Ear Barotrauma
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Middle ear barotrauma (MEB) is the most common complication during hyperbaric oxygen therapy (HBOT). Though Valsalva and Toynbee maneuvers have been proposed to prevent MEB, still some patients discon...
Eligibility Criteria
Inclusion
- Aged 20 years or order receiving the first HBOT
- Alert consciousness
Exclusion
- Pregnancy
- Having any acute disorder of the ears or upper respiratory tract
- Having evidence of neurologic dysfunction precluding them from making an informed decision
- Having a tracheostomy or endotracheal intubation
- Having received a myringotomy, tympanoplasty, mastoidectomy or tympanostomy tube placement.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2023
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT04311437
Start Date
March 1 2020
End Date
February 28 2023
Last Update
March 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan, 833